Latest Rockefeller University Stories
A scientist awarded the Nobel prize for his research in cancer died of the disease just days before he was told about the award.
Take a second look at your iced or steaming tea.
NEW YORK, July 21, 2011 /PRNewswire/ -- Honoring biomedical advances impacting both individual lives and public health in the past decade, the Prix Galien USA committee today announced the 2011 final candidates for the 5th annual Prix Galien Awards competition.
PHILADELPHIA, June 14, 2011 /PRNewswire-USNewswire/ -- The Pew Charitable Trusts named 10 outstanding early-career scientists to be Pew Latin American Fellows in the Biomedical Sciences.
Scientists at Rockefeller University and The Scripps Research Institute have developed the first genetically humanized mouse model for hepatitis C, an achievement that will enable researchers to test molecules that block entry of the hepatitis C virus into cells as well as potential vaccine candidates.
Forests in many regions are becoming larger carbon sinks thanks to higher density, US and European researchers say in a new report.
NEW YORK, June 2, 2011 /PRNewswire/ -- Over 1000 guests will pack New York's American Museum of Natural History tonight to honor David W. Levinson, Chairman and CEO of L&L Holding Company.
A recent US study suggests that aspirin and other anti-inflammatory drugs, including ibuprofen and naproxen, may reduce the effectiveness of the most widely used anti-depressant medications -- selective serotonin reuptake inhibitors (SSRIs).
Scientists at the Fisher Center for Alzheimer's Disease Research at The Rockefeller University, led by Paul Greengard, Ph.D., and Jennifer Warner-Schmidt, Ph.D., have shown that anti-inflammatory drugs, which include ibuprofen, aspirin and naproxen, reduce the effectiveness of the most widely used class of antidepressant medications, the selective serotonin reuptake inhibitors, or SSRIs, taken for depression and obsessive-compulsive disorder and anxiety disorders.
More Images (1 images) »